Literature DB >> 8175790

NK-kappa B subunit-specific regulation of the I kappa B alpha promoter.

Q Cheng1, C A Cant, T Moll, R Hofer-Warbinek, E Wagner, M L Birnstiel, F H Bach, R de Martin.   

Abstract

Stimulation of endothelial cells by cytokines and bacterial lipopolysaccharide leads to activation of the transcription factor NF-kappa B. NF-kappa B in turn regulates the expression of several genes involved in the inflammatory reaction, including cell adhesion molecules, interleukins, and transcription factors. One of these induced genes encodes an inhibitor of NF-kappa B, ECI-6/I kappa B alpha, that contains in its 5' regulatory region six consensus binding sites for NF-kappa B. We demonstrate here that these sites display striking differences in their ability in vitro to bind to various NF-kappa B subunits. In vivo, all six sites contribute, though to varying degrees, to transcription from the ECI-6/I kappa B alpha promoter, as demonstrated by deletion and mutation analysis. Among the NF-kappa B subunits tested p65, the p65/p50 heterodimer and, to a lesser extent, c-Rel, are able to activate transcription, whereas p50 or p50/Re1B were inactive. Since many genes regulated by NF-kappa B contain only one or two DNA-binding sites for this transcription factor, the presence of six functional NF-kappa B-binding sites in the ECI-6/I kappa B alpha promoter represents a unique feature of this gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175790

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha.

Authors:  T T Huang; S Miyamoto
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.

Authors:  T T Huang; N Kudo; M Yoshida; S Miyamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  RelB regulation of chemokine expression modulates local inflammation.

Authors:  Y Xia; M E Pauza; L Feng; D Lo
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

4.  Regulation and function of nuclear IκBα in inflammation and cancer.

Authors:  Ivana Vancurova; Ales Vancura
Journal:  Am J Clin Exp Immunol       Date:  2012-05-25

5.  AP-1 factors play an important role in transformation induced by the v-rel oncogene.

Authors:  J Kralova; A S Liss; W Bargmann; H R Bose
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B.

Authors:  J Anrather; V Csizmadia; C Brostjan; M P Soares; F H Bach; H Winkler
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

7.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.

Authors:  J F Klement; N R Rice; B D Car; S J Abbondanzo; G D Powers; P H Bhatt; C H Chen; C A Rosen; C L Stewart
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

Review 8.  Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Mediators Inflamm       Date:  2010-04-12       Impact factor: 4.711

9.  Chlorogenic acid attenuates adhesion molecules upregulation in IL-1beta-treated endothelial cells.

Authors:  Weng-Cheng Chang; Chia-Hsin Chen; Ming-Fen Lee; Ted Chang; Ya-Mei Yu
Journal:  Eur J Nutr       Date:  2009-11-24       Impact factor: 5.614

10.  Induction of RIP-2 kinase by proinflammatory cytokines is mediated via NF-kappaB signaling pathways and involves a novel feed-forward regulatory mechanism.

Authors:  Xixi Yin; Paul Krikorian; Thomas Logan; Vilmos Csizmadia
Journal:  Mol Cell Biochem       Date:  2009-08-20       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.